The Editorial Board is again pleased to offer its warmest congratulations to the winner of the 2023 Cushing’s Hub Competition, Dr Shobana Athimulam, Assistant Professor of Medicine, Henry Ford Health, Detroit, MI, USA whose excellent Interactive Clinical Case is now available online.

Dr Athimulam clearly explains the evaluation of adrenal incidentalomas, which are present in approximately 5% of individuals subject to cross-sectional abdominal imaging. Given that up to half of these lesions are functional, widespread exposure to chronic low-level cortisol excess and its link to serious co-morbidities such as hypertension, dyslipidaemia, pre-diabetes, and osteopenia, is a major concern, at both the individual and population level.

To learn more about the challenges associated with mild autonomous cortisol secretion, including work-up, assessment of related comorbidities, and personalised treatment plans, click below.

The Cushing’s Hub Editorial Board is delighted to announce the release of the webcast from the second event in the Cushing’s Hub Webinar Series – Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS) – held on Tuesday 24 October.

Chaired by Dr Susan M. Webb, Barcelona, Spain, this webcast sees panelists Assoc. Prof. Iacopo Chiodini, Milan, Italy and Dr Irina Bancos, Rochester, MN, USA, discuss, using a case-centred approach, the clinical management of low-grade excessive cortisol secretion and take questions from the audience.

The live event, and webcast, Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS), 24/10/23, have been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credit (ECMEC®).

Latest from across Cushing's Hub
March 27, 2024

Researchers have developed a machine learning tool that could help in the differential diagnosis of adrenocorticotropic hormone-dependent Cushing’s syndrome, potentially avoiding the need for bilateral inferior petrosal sinus sampling.

March 1, 2024

Patients with Cushing’s disease who achieve remission following surgery have an increased incidence of autoimmune disease, suggest findings published in the Annals of Internal Medicine in February 2024.

February 29, 2024

The last day of February is international Rare Disease Day. In 2024, it’s on Thursday 29 February.
The main aim of the day is to raise aware of rare disease within the general public, but also among policy makers, public authorities, industry representatives, researchers, and healthcare professionals.

In January 2023, Cushing’s Hub warmly welcomed a new Editorial Board – read on to see what the team have to say about their new role.